Deep Bio

Deep Bio to Present Research Findings at Poster Sessions during AACR Annual Meeting 2024

Three posters will be presented at the AACR Annual Meeting 2024 to spotlight Deep Bio’s pioneering research and advancements in AI within digital pathology. Deep Bio, a frontrunner in AI-powered...

Deep Bio To Present Their Research Findings At The Poster Sessions During The USCAP 113th Annual Meeting

Four research results will be presented to validate Deep Bio’s pioneering research and breakthroughs in AI advancements in digital pathology. SEOUL, SOUTH KOREA, March 19, 2024 /EINPresswire.com/ R...

Deep Bio’s DeepDx Prostate Featured in CancerX’s Solutions Catalog, Pioneering Digital Innovation in Oncology

Deep Bio, a pioneer of AI-powered cancer diagnostics solutions, proudly announced the inclusion of DeepDx Prostate in CancerX’s Solutions Catalog. This significant participation positions Deep B...

DeepBio Wins The CES Innovation Award For Pioneering, A New Milestone In Korean Cancer Diagnostic AI Solutions

DeepBio won the CES Innovation Award for pioneering a new milestone in Korean cancer diagnosis A.I. solutions. DeepBio has announced that it has been awarded the CES Innovation Award as the first Kore...

Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and Prognosis with AI Expertise

SEOUL, South Korea – Deep Bio, a leading AI healthcare company specializing in deep learning and cancer pathology, is proud to announce its participation in the groundbreaking CancerX initiative...

Deep Bio Earns Coveted Spot in Korea AI Startup 100 List for the Third Consecutive Year

Deep Bio, a leader in artificial intelligence (AI)-powered cancer diagnostics, announced today that it has been named on the Korea AI Startup 100 list. This prestigious list, representing a recognitio...

Join Deep Bio At AACR And Discover How DeepDx® Prostate Is Empowering Pathologists

Are you ready to learn about the latest breakthroughs in digital pathology? Join Deep Bio at booth #3445 and discover how DeepDx® Prostate is empowering pathologists to diagnose and treat prostate can...

Deep Bio’s Novel Study Results Reaffirm Its Global Presence

SEOUL, SOUTH KOREA (PRWEB) MARCH 14, 2023 Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support software shared three research abstracts at the United States and Canad...

Deep Bio and Visiopharm announce a collaborative integration of a clinical-grade AI prostate cancer solution with a leading digital pathology platform

Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered image analysis and tissue mining for research and diagnostics, announced a strategic partners...

  • 1
  • 2